• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌导管内生长亚型术后生存率提高

Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.

作者信息

Dover Laura L, Jacob Rojymon, Wang Thomas N, Richardson Joseph H, Redden David T, Li Peng, DuBay Derek A

机构信息

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

Am Surg. 2016 Nov 1;82(11):1133-1139.

PMID:28206944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5748294/
Abstract

Intrahepatic cholangiocarcinoma (ICC) is classified according to the following subtypes: massforming (MF), periductal infiltrating (PI), and intraductal growth (IG). The aim of this study is to measure the association between ICC subtypes and patient survival after surgical resection. Data were abstracted on all patients treated with definitive resections of ICC at a single institution between 2000 and 2011 with at least three years follow-up. Survival estimates were quantified using Kaplan-Meier curves and compared using the log-rank test. There were 37 patients with ICC treated with definitive partial hepatectomies with a median survival of 33.5 months. Tumor stage (P < 0.0001), satellitosis (P < 0.001), lymphovascular space invasion (P = 0.003), and macroscopic subtype (P = 0.003) were predictive of postoperative survival. Disease-free survivals for MF, PI, and IG subtypes, respectively, were 30 per cent, 0 per cent, and 57 per cent (P = 0.017). Overall survivals among ICC macroscopic subtypes were as follows: MF 37 per cent, PI 0 per cent, and IG 71 per cent (P = 0.003). Although limited by the small sample size of this rare cancer, this study demonstrates significant differences among macroscopic subtypes of ICC in both disease-free survivals and overall survivals after definitive partial hepatectomy.

摘要

肝内胆管癌(ICC)根据以下亚型进行分类:肿块型(MF)、胆管周围浸润型(PI)和管内生长型(IG)。本研究的目的是衡量ICC亚型与手术切除后患者生存率之间的关联。提取了2000年至2011年在单一机构接受ICC根治性切除术且至少随访三年的所有患者的数据。使用Kaplan-Meier曲线对生存估计进行量化,并使用对数秩检验进行比较。有37例接受根治性部分肝切除术的ICC患者,中位生存期为33.5个月。肿瘤分期(P<0.0001)、卫星灶(P<0.001)、淋巴管间隙侵犯(P=0.003)和大体亚型(P=0.003)可预测术后生存。MF、PI和IG亚型的无病生存率分别为30%、0%和57%(P=0.017)。ICC大体亚型的总生存率如下:MF为37%,PI为0%,IG为71%(P=0.003)。尽管本研究受这种罕见癌症样本量小的限制,但它表明了ICC大体亚型在根治性部分肝切除术后的无病生存率和总生存率方面存在显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/081ae970803f/nihms929965f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/ecae95cb0d05/nihms929965f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/273df0527110/nihms929965f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/f1cbe3da83f7/nihms929965f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/081ae970803f/nihms929965f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/ecae95cb0d05/nihms929965f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/273df0527110/nihms929965f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/f1cbe3da83f7/nihms929965f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaa5/5748294/081ae970803f/nihms929965f4.jpg

相似文献

1
Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.肝内胆管癌导管内生长亚型术后生存率提高
Am Surg. 2016 Nov 1;82(11):1133-1139.
2
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
3
Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.预测肝内胆管癌手术切除后生存率的模型:梅奥诊所的经验
HPB (Oxford). 2015 Mar;17(3):244-50. doi: 10.1111/hpb.12333. Epub 2014 Nov 19.
4
Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.肝内胆管细胞癌根治性切除术后的预后与内脏浸润密切相关——单中心连续 102 例肝切除术的回顾性队列研究。
Int J Surg. 2018 Jul;55:193-200. doi: 10.1016/j.ijsu.2018.05.027. Epub 2018 May 25.
5
Comparison of clinicopathological characteristics between patients with occupational and non-occupational intrahepatic cholangiocarcinoma.职业性与非职业性肝内胆管癌患者临床病理特征的比较。
J Hepatobiliary Pancreat Sci. 2016 Jul;23(7):389-96. doi: 10.1002/jhbp.353. Epub 2016 May 3.
6
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.形态学状态对肝内胆管细胞癌患者肝切除术后长期预后的影响。
Ann Surg Oncol. 2017 Sep;24(9):2491-2501. doi: 10.1245/s10434-017-5870-y. Epub 2017 May 2.
7
Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.呈现肝内胆管生长的肝内胆管细胞癌的临床病理特征
J Surg Oncol. 2009 Mar 1;99(3):161-5. doi: 10.1002/jso.21214.
8
Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.肝门部胆管癌的切除与引流:中国大陆单中心11年经验
Am Surg. 2011 May;77(5):627-33.
9
Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma.肝内胆管细胞癌管内生长型患者的长期预后。
HPB (Oxford). 2018 Dec;20(12):1189-1197. doi: 10.1016/j.hpb.2018.05.017. Epub 2018 Jun 27.
10
Outcomes following resection of intrahepatic cholangiocarcinoma.肝内胆管癌切除术后的结果。
HPB (Oxford). 2015 Apr;17(4):344-51. doi: 10.1111/hpb.12359. Epub 2014 Nov 14.

引用本文的文献

1
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.世界卫生组织肝内胆管癌亚型分类的外科解读:一篇综述
Surg Today. 2025 Jan;55(1):1-9. doi: 10.1007/s00595-024-02825-x. Epub 2024 Apr 2.
2
Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line, ICC-X2.一种新的肝内胆管癌细胞系ICC-X2的建立与鉴定
World J Oncol. 2024 Feb;15(1):114-125. doi: 10.14740/wjon1757. Epub 2024 Jan 10.
3
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma.

本文引用的文献

1
Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.进行综述以更好地了解肝内胆管癌的大体亚型和组织发生。
World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):188-99. doi: 10.4291/wjgp.v5.i3.188.
2
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.肝内胆管癌的形态学亚分类:病因、临床病理及分子特征
Mod Pathol. 2014 Aug;27(8):1163-73. doi: 10.1038/modpathol.2013.241. Epub 2014 Jan 10.
3
K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy.
肝内胆管癌的新辅助治疗和辅助治疗
J Clin Transl Hepatol. 2022 Jun 28;10(3):553-563. doi: 10.14218/JCTH.2021.00250. Epub 2022 Jan 4.
4
Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.肿块型肝内胆管癌患者的预后因素:68例病例系列研究
World J Gastrointest Surg. 2022 May 27;14(5):442-451. doi: 10.4240/wjgs.v14.i5.442.
5
Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.长链非编码 RNA LINC01296 通过海绵吸附 miR-5095 促进人胆管癌的肿瘤生长和进展。
Int J Oncol. 2018 Jun;52(6):1777-1786. doi: 10.3892/ijo.2018.4362. Epub 2018 Apr 5.
6
Macroscopic types of intrahepatic cholangiocarcinoma and the eighth edition of AJCC/UICC TNM staging system.肝内胆管癌的大体类型与美国癌症联合委员会/国际抗癌联盟(AJCC/UICC)第八版TNM分期系统
Oncotarget. 2017 Sep 15;8(60):101165-101174. doi: 10.18632/oncotarget.20932. eCollection 2017 Nov 24.
K-ras 基因突变与神经周围侵犯密切相关,是肝切除术后肝内胆管癌的独立预后因素。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S675-81. doi: 10.1245/s10434-012-2224-7.
4
Clinical diagnosis and staging of cholangiocarcinoma.胆管癌的临床诊断和分期。
Nat Rev Gastroenterol Hepatol. 2011 Aug 2;8(9):512-22. doi: 10.1038/nrgastro.2011.131.
5
Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas.多中心评估临床和预后评分系统对肝内胆管细胞癌切除术后生存的预测价值。
Liver Int. 2010 Aug;30(7):996-1002. doi: 10.1111/j.1478-3231.2010.02203.x. Epub 2010 Feb 5.
6
[Current management and prognosis of intrahepatic cholangiocarcinoma in France].[法国肝内胆管癌的当前管理与预后]
Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):971-6. doi: 10.1016/j.gcb.2009.05.012. Epub 2009 Jul 31.
7
Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.肝内胆管癌手术:单中心158例患者的经验
J Am Coll Surg. 2009 Feb;208(2):218-28. doi: 10.1016/j.jamcollsurg.2008.10.017.
8
Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification.肝内胆管癌扩大肝切除术:TNM 分类第五版和第六版预后准确性的比较
Ann Surg. 2009 Feb;249(2):303-9. doi: 10.1097/SLA.0b013e318195e164.
9
Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.呈现肝内胆管生长的肝内胆管细胞癌的临床病理特征
J Surg Oncol. 2009 Mar 1;99(3):161-5. doi: 10.1002/jso.21214.
10
A proposed staging system for intrahepatic cholangiocarcinoma.一种针对肝内胆管癌的拟议分期系统。
Ann Surg Oncol. 2009 Jan;16(1):14-22. doi: 10.1245/s10434-008-0180-z. Epub 2008 Nov 6.